Skip to main content

Peer Review reports

From: Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer

Original Submission
8 Jan 2022 Submitted Original manuscript
27 Jan 2022 Reviewed Reviewer Report
1 Feb 2022 Reviewed Reviewer Report - Nelson Dusetti
22 Mar 2022 Author responded Author comments - Sadanori Watanabe
Resubmission - Version 2
22 Mar 2022 Submitted Manuscript version 2
28 Mar 2022 Author responded Author comments - Sadanori Watanabe
Resubmission - Version 3
28 Mar 2022 Submitted Manuscript version 3
2 Apr 2022 Author responded Author comments - Sadanori Watanabe
Resubmission - Version 4
2 Apr 2022 Submitted Manuscript version 4
11 Apr 2022 Reviewed Reviewer Report - Nelson Dusetti
20 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
25 Apr 2022 Editorially accepted
3 May 2022 Article published 10.1186/s12885-022-09619-9

You can find further information about peer review here.

Back to article page